The latest closing stock price for Tempest Therapeutics as of February 21, 2025 is 0.86.
An investor who bought $1,000 worth of Tempest Therapeutics stock at the IPO in 2012 would have $-999 today, roughly -1 times their original investment - a -46.84% compound annual growth rate over 12 years.
The all-time high Tempest Therapeutics stock closing price was 12028.49 on March 24, 2015.
The Tempest Therapeutics 52-week high stock price is 6.00, which is 597.7% above the current share price.
The Tempest Therapeutics 52-week low stock price is 0.70, which is 18.6% below the current share price.
The average Tempest Therapeutics stock price for the last 52 weeks is 1.98.
An investor who bought $1,000 worth of Tempest Therapeutics stock at the IPO in 2012 would have $-999 today, roughly -1 times their original investment - a -46.84% compound annual growth rate over 12 years.
The all-time high Tempest Therapeutics stock closing price was 12028.49 on March 24, 2015.
The Tempest Therapeutics 52-week high stock price is 6.00, which is 597.7% above the current share price.
The Tempest Therapeutics 52-week low stock price is 0.70, which is 18.6% below the current share price.
The average Tempest Therapeutics stock price for the last 52 weeks is 1.98.